Effects of Clinically Used Antioxidants in Experimental Pneumococcal Meningitis
about
Transcriptome analysis of murine macrophages in response to infection with Streptococcus pyogenes reveals an unusual activation programPrevention of brain injury by the nonbacteriolytic antibiotic daptomycin in experimental pneumococcal meningitisGene expression in cortex and hippocampus during acute pneumococcal meningitisAnti-neuroinflammatory effects of the extract of Achillea fragrantissima.New therapies and vaccines for bacterial meningitis.Emerging molecular targets in the treatment of bacterial meningitis.Reprogramming the host response in bacterial meningitis: how best to improve outcome?Mechanisms of disease: the blood-brain barrier.Streptococcus pneumoniae secretes hydrogen peroxide leading to DNA damage and apoptosis in lung cells.Review: apoptotic mechanisms in bacterial infections of the central nervous system.Current concepts in the treatment of bacterial meningitis beyond the neonatal period.The causative pathogen determines the inflammatory profile in cerebrospinal fluid and outcome in patients with bacterial meningitisAnimal models of Streptococcus pneumoniae diseaseEmerging drugs for acute bacterial meningitis.Therapy of community-acquired acute bacterial meningitis: the clock is running.Bacterial meningitis: current therapy and possible future treatment options.Use of corticosteroids and other adjunct therapies for acute bacterial meningitis in adults.Bacterial meningitis: new therapeutic approaches.Bacterial meningitis: insights into pathogenesis and evaluation of new treatment options: a perspective from experimental studies.Bacterial meningitis: an update of new treatment options.Adjunctive N-acetyl-L-cysteine in treatment of murine pneumococcal meningitis.Dexamethasone aggravates hippocampal apoptosis and learning deficiency in pneumococcal meningitis in infant rats.Cerebral vasculature is the major target of oxidative protein alterations in bacterial meningitis.Antioxidant treatment prevents cognitive impairment and oxidative damage in pneumococcal meningitis survivor rats.Induction of haem oxygenase-1 causes cortical non-haem iron increase in experimental pneumococcal meningitis: evidence that concomitant ferritin up-regulation prevents iron-induced oxidative damage.Combined effect of non-bacteriolytic antibiotic and inhibition of matrix metalloproteinases prevents brain injury and preserves learning, memory and hearing function in experimental paediatric pneumococcal meningitis
P2860
Q28590403-9DED8EE9-1EE0-401E-8A8D-B1DCB4A45359Q28757559-20800D44-BF16-4A8E-BD27-689AC98450FAQ30817171-FCFC4CF3-5A4B-43DF-8C8B-8842100AB5B1Q34053940-8C7840E7-8C49-44E7-9879-8E3EE946F417Q34768547-B22DF4E3-31C1-418E-BAA2-839C7F924B2CQ35095121-05E2EEB0-917D-49F9-A255-20DDE435EE3EQ35176266-AA34783D-D633-47DC-A867-BB85F898A2F3Q35610735-5154B3F9-443D-4728-89AB-2495B33F7F29Q35818866-01A02082-D471-4AFA-AC6C-93F4CFF7C69CQ36296389-06803400-EAE1-473A-8B0B-D9CB6BF546A1Q36607421-A946B44C-0819-49EC-9B38-849A51E579A3Q36995799-A0BDD5F4-598C-48CC-A33F-1B6FC4ACBE3AQ37293669-D034479E-FA56-48F0-A566-F0F92EF172D4Q37558543-62D9CB8E-943B-4CAC-93F4-006D7B993590Q37614552-F2540EEC-97AF-4BC8-B67A-EF4C62EF2BB1Q37949641-B3998B6B-1DED-4DA2-A221-704E68121BDDQ38017147-180E9A31-31AE-41CB-AC44-3F2A5B3FB22BQ38145360-AF42D861-DC4D-461C-90E4-EB20B25A67F5Q38539643-B0E2E6D0-C096-40A4-A375-E9C8942E087EQ38570487-3CBE41B6-9668-4836-A96C-849A60E54CEEQ42065261-B156FC7D-D17D-4895-93D2-E4829A2D2A61Q43802111-27B0F53E-B98B-4684-8079-6B7EB510FDCDQ44069454-7549C6AB-F19C-4958-ADFC-DE7320CEDA72Q45230516-9F99D80F-B5E5-4CC5-827C-3A65B52405D2Q48363903-B3870C38-3AC2-4860-95D5-DF989BE99D31Q57253129-4E8B4A8D-4F23-456D-B2E9-5128A1EA0995
P2860
Effects of Clinically Used Antioxidants in Experimental Pneumococcal Meningitis
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Effects of Clinically Used Antioxidants in Experimental Pneumococcal Meningitis
@en
Effects of Clinically Used Antioxidants in Experimental Pneumococcal Meningitis
@nl
type
label
Effects of Clinically Used Antioxidants in Experimental Pneumococcal Meningitis
@en
Effects of Clinically Used Antioxidants in Experimental Pneumococcal Meningitis
@nl
prefLabel
Effects of Clinically Used Antioxidants in Experimental Pneumococcal Meningitis
@en
Effects of Clinically Used Antioxidants in Experimental Pneumococcal Meningitis
@nl
P2093
P356
P1476
Effects of clinically used antioxidants in experimental pneumococcal meningitis
@en
P2093
P304
P356
10.1086/315658
P407
P577
2000-07-06T00:00:00Z